MCF Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.8K | Hold |
30
| – | – | ﹤0.01% | 589 |
|
|
2025
Q1 | $19K | Sell |
30
-6
| -17% | -$3.81K | ﹤0.01% | 561 |
|
|
2024
Q4 | $25.6K | Hold |
36
| – | – | ﹤0.01% | 509 |
|
|
2024
Q3 | $37.8K | Sell |
36
-5
| -12% | -$5.26K | ﹤0.01% | 437 |
|
|
2024
Q2 | $43.1K | Buy |
41
+6
| +17% | +$6.31K | ﹤0.01% | 410 |
|
|
2024
Q1 | $33.7K | Sell |
35
-1
| -3% | -$963 | ﹤0.01% | 443 |
|
|
2023
Q4 | $31.6K | Buy |
36
+12
| +50% | +$10.5K | ﹤0.01% | 440 |
|
|
2023
Q3 | $19.8K | Hold |
24
| – | – | ﹤0.01% | 488 |
|
|
2023
Q2 | $17.2K | Hold |
24
| – | – | ﹤0.01% | 497 |
|
|
2023
Q1 | $19.7K | Buy |
24
+20
| +500% | +$16.4K | ﹤0.01% | 475 |
|
|
2022
Q4 | $2.89K | Hold |
4
| – | – | ﹤0.01% | 642 |
|
|
2022
Q3 | $3K | Hold |
4
| – | – | ﹤0.01% | 653 |
|
|
2022
Q2 | $2K | Hold |
4
| – | – | ﹤0.01% | 640 |
|
|
2022
Q1 | $3K | Buy |
+4
| New | +$3K | ﹤0.01% | 613 |
|
|
2021
Q4 | – | Sell |
-4
| Closed | -$2K | – | 529 |
|
|
2021
Q3 | $2K | Buy |
+4
| New | +$2K | ﹤0.01% | 630 |
|